These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 18328984)
1. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders. Ralston SH Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):101-11. PubMed ID: 18328984 [TBL] [Abstract][Full Text] [Related]
2. Contribution of genetic factors to the pathogenesis of Paget's disease of bone and related disorders. Lucas GJ; Daroszewska A; Ralston SH J Bone Miner Res; 2006 Dec; 21 Suppl 2():P31-7. PubMed ID: 17229006 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: genetics of Paget's disease of bone and related disorders. Daroszewska A; Ralston SH Nat Clin Pract Rheumatol; 2006 May; 2(5):270-7. PubMed ID: 16932700 [TBL] [Abstract][Full Text] [Related]
4. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. Whyte MP Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914 [TBL] [Abstract][Full Text] [Related]
5. Rare Inherited forms of Paget's Disease and Related Syndromes. Ralston SH; Taylor JP Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140 [TBL] [Abstract][Full Text] [Related]
6. Genetics of Paget's disease of bone. Daroszewska A; Ralston SH Clin Sci (Lond); 2005 Sep; 109(3):257-63. PubMed ID: 16104845 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. Daroszewska A; Hocking LJ; McGuigan FE; Langdahl B; Stone MD; Cundy T; Nicholson GC; Fraser WD; Ralston SH J Bone Miner Res; 2004 Sep; 19(9):1506-11. PubMed ID: 15312251 [TBL] [Abstract][Full Text] [Related]
8. Familial Paget's disease of bone with ocular manifestations and a novel TNFRSF11A duplication variant (72dup27). Saito-Hakoda A; Kikuchi A; Takahashi T; Yokoyama Y; Himori N; Adachi M; Ikeda R; Nomura Y; Takayama J; Kawashima J; Katsuoka F; Fujishima F; Yamaguchi T; Ito A; Hanita T; Kanno J; Aizawa T; Nakazawa T; Kawase T; Tamiya G; Yamamoto M; Fujiwara I; Kure S J Bone Miner Metab; 2023 Mar; 41(2):193-202. PubMed ID: 36520195 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Lucas GJ; Mehta SG; Hocking LJ; Stewart TL; Cundy T; Nicholson GC; Walsh JP; Fraser WD; Watts GD; Ralston SH; Kimonis VE Bone; 2006 Feb; 38(2):280-5. PubMed ID: 16199218 [TBL] [Abstract][Full Text] [Related]
10. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK. Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546 [TBL] [Abstract][Full Text] [Related]
11. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Hughes AE; Ralston SH; Marken J; Bell C; MacPherson H; Wallace RG; van Hul W; Whyte MP; Nakatsuka K; Hovy L; Anderson DM Nat Genet; 2000 Jan; 24(1):45-8. PubMed ID: 10615125 [TBL] [Abstract][Full Text] [Related]
14. Valosin-containing protein gene mutations: clinical and neuropathologic features. Guyant-Maréchal L; Laquerrière A; Duyckaerts C; Dumanchin C; Bou J; Dugny F; Le Ber I; Frébourg T; Hannequin D; Campion D Neurology; 2006 Aug; 67(4):644-51. PubMed ID: 16790606 [TBL] [Abstract][Full Text] [Related]
15. Genetics and aetiology of Pagetic disorders of bone. Helfrich MH; Hocking LJ Arch Biochem Biophys; 2008 May; 473(2):172-82. PubMed ID: 18359282 [TBL] [Abstract][Full Text] [Related]
16. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. Whyte MP; Hughes AE J Bone Miner Res; 2002 Jan; 17(1):26-9. PubMed ID: 11771666 [TBL] [Abstract][Full Text] [Related]
17. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. Sparks AB; Peterson SN; Bell C; Loftus BJ; Hocking L; Cahill DP; Frassica FJ; Streeten EA; Levine MA; Fraser CM; Adams MD; Broder S; Venter JC; Kinzler KW; Vogelstein B; Ralston SH Calcif Tissue Int; 2001 Mar; 68(3):151-5. PubMed ID: 11351498 [TBL] [Abstract][Full Text] [Related]
18. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy. Craven M; Vajravelu ME; Shekdar KV; Levine MA; Mumm S; Whyte MP; Mancilla EE Bone; 2023 May; 170():116698. PubMed ID: 36740137 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical response of TNFRSF11A-mediated early-onset familial Paget disease to bisphosphonate therapy. Riches PL; Imanishi Y; Nakatsuka K; Ralston SH Calcif Tissue Int; 2008 Oct; 83(4):272-5. PubMed ID: 18836673 [TBL] [Abstract][Full Text] [Related]
20. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Guinto JB; Ritson GP; Taylor JP; Forman MS Acta Neuropathol; 2007 Jul; 114(1):55-61. PubMed ID: 17457594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]